Stock analysts at Citizens Jmp assumed coverage on shares of RXO (NYSE:RXO – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “market perform” rating on the stock.
Several other equities research analysts have also weighed in on the company. Citigroup started coverage on RXO in a research note on Wednesday. They set a “market perform” rating for the company. Barclays increased their price target on RXO from $20.00 to $28.00 and gave the company an “overweight” rating in a research report on Thursday, June 25th. Stifel Nicolaus lifted their price target on RXO from $22.00 to $30.00 and gave the stock a “buy” rating in a research note on Monday. Bank of America cut their price objective on RXO from $17.00 to $15.00 and set a “neutral” rating on the stock in a report on Wednesday, March 25th. Finally, Weiss Ratings raised shares of RXO from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, June 4th. Four investment analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $23.14.
Read Our Latest Research Report on RXO
RXO Trading Up 3.6%
RXO (NYSE:RXO – Get Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported ($0.09) EPS for the quarter, hitting analysts’ consensus estimates of ($0.09). RXO had a negative return on equity of 1.16% and a negative net margin of 1.83%.The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.34 billion. During the same quarter in the previous year, the business earned ($0.03) EPS. The company’s quarterly revenue was down .6% compared to the same quarter last year. As a group, analysts anticipate that RXO will post 0.08 earnings per share for the current fiscal year.
Institutional Investors Weigh In On RXO
A number of institutional investors have recently bought and sold shares of the business. Massachusetts Financial Services Co. MA increased its holdings in RXO by 20.7% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 1,110,413 shares of the company’s stock worth $14,036,000 after buying an additional 190,583 shares during the last quarter. Vanguard Group Inc. raised its holdings in shares of RXO by 0.5% during the 4th quarter. Vanguard Group Inc. now owns 17,309,811 shares of the company’s stock valued at $218,796,000 after purchasing an additional 93,130 shares in the last quarter. Vaughan Nelson Investment Management L.P. bought a new position in shares of RXO during the 4th quarter valued at $11,224,000. Patten Group Inc. acquired a new position in RXO during the fourth quarter worth $404,000. Finally, Hudson Bay Capital Management LP bought a new stake in RXO during the third quarter worth approximately $2,084,000. 92.73% of the stock is currently owned by institutional investors and hedge funds.
About RXO
RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.
Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.
Featured Articles
- Five stocks we like better than RXO
- As the Iran War Resumes, 2 Energy ETFs Ride Oil’s Renewed Rally
- Tower Semiconductor’s AI Rally Is Built on a Light-Speed Bet
- Marriott vs. Viking: Why the Better Quarter Doesn’t Mean the Better Decade
- Why Fastenal’s Latest Drop Could Be Its Biggest Opportunity Yet
Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.
